Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
GOG 218 schema. The second study is a | Download Scientific Diagram
Outcome results of GOG 218 and ICON7 | Download Table
GOG 218 and ICON7 adverse events | Download Table
GOG 252 schema. The activity of bevacizumab in patients with recurrent ...
GOG 240 Bevacizumab in carcinoma cervix | PPTX | Cancer | Diseases and ...
GOG 240 Bevacizumab in carcinoma cervix | PPTX
Long Term Survival of GOG 252 ‘Randomized Trial of Intravenous Versus ...
PPT - Maintenance Therapy for Ovarian Cancer – Do the Benefits Outweigh ...
PPT - The emerging role of targeted therapy in treatment of epithelial ...
PPT - Novel Therapeutics in Gynecological Malignancies PowerPoint ...
PPT - GOG0172: The Dings PowerPoint Presentation, free download - ID ...
Targeted therapy in ovarian cancer | PDF
PPT - At initial diagnosis PowerPoint Presentation, free download - ID ...
Biomarkers in the development of anti-angiogenic therapies for ovarian ...
advanced stage ovary tumor.pptx
PPT - GOG-0218: Background and Rationale PowerPoint Presentation, free ...
PPT - Management of Epithelial Ovarian Cancer PowerPoint Presentation ...
PPT - Investigating the Role of Anti-Angiogenic Agents in Ovarian ...
PPT - OVARIAN CANCER COMMITTEE Phillip Harter / Christian Marth ...
GOG-218: Academic analysis of PFS | Download Scientific Diagram
PARP-Inhibitoren, VEGF-Antikörper – Ovarialkarzinom | SPECTRUM Onkologie
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary ...
Targeted therapy in frontline treatment of advanced ovarian cancer ...
(PDF) Bevacizumab in the primary treatment of epithelial ovarian cancer ...
Avastin® (bevacizumab) Clinical Trials for Ovarian Cancer | HCP
Mutations in Homologous Recombination Genes and Outcomes in Ovarian ...
Targeted agents in epithelial ovarian cancer: review on emerging ...
Cost-effectiveness of adding bevacizumab to first line therapy for ...
PPT - UPDATE ON GCIG TRIALS FOR EPITHELIAL OVARIAN CANCER Christian ...
Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian ...
A practical prediction model for determining bevacizumab response and ...
Phase III bevacizumab trials in ovary cancer | Download Table
References in Standard chemotherapy with or without bevacizumab in ...
GOG-218: Bevacizumab plus standard chemo for ovarian cancer - ecancer
Development of bevacizumab in advanced cervical cancer: pharmacodynamic ...
The use of bevacizumab in the modern era of targeted therapy for ...
(PDF) Bevacizumab in combination with chemotherapy for the treatment of ...
Identification of Patients With Ovarian Cancer Experiencing the Highest ...
(PDF) Identification of Patients With Ovarian Cancer Experiencing the ...
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer ...
GOG-0218: Frontline Bevacizumab in Ovarian Cancer
Cost effectiveness of bevacizumab plus carboplatin paclitaxel versus ...
A Phase 3 Trial of Bevacizumab in Ovarian Cancer | NEJM
PPT - Ovarian cancer with update from ASCO 2013 PowerPoint Presentation ...
Ovarian Cancer: Standards of Care and New Opportunities - ppt video ...
吴小华教授：BRCA野生型患者到底要不要维持治疗？怎么维持？ - 知乎
Frontiers | Bevacizumab in ovarian cancer therapy: current advances ...
Knowledge is Power: ovarian cancer | PPT
Landmark trials in Ovarian Cancer | PPTX
Optimal first-line treatment in ovarian cancer - Annals of Oncology
Correlation of imaging and plasma based biomarkers to predict response ...
The role of bevacizumab in targeted vascular endothelial growth factor ...
(PDF) Identification of patients with ovarian cancer who are ...
Bevacizumab for advanced cervical cancer: final overall survival and ...
State of the art of the management of advanced and recurrent ovarian ...
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS | Bevacizumab bevacizumab in ...
Comparison of Kaplan–Meier curves between GOG218 study, PRIMA study ...
Efficacy data of bevacizumab in first line for ovarian cancer in Phase ...
PPT - SURGICAL MANAGEMENT OF PRIMARY EPITHELIAL OVARIAN CANCER ...
GOG-218の解析データについてのSupplementary Materialの解説｜産婦人科医とみー
Figure 1 from Bevacizumab and paclitaxel-carboplatin chemotherapy and ...
(PDF) Bevacizumab for advanced ovarian cancer treatment. A GRADE based ...
PPT - Pazopanib in Advanced Ovarian Cancer: A new galloping horse ...
Adjuvant Chemotherapy + Bevacizumab for Ovarian Cancer - YouTube
Independent radiologic review of GOG218, a phase III trial of ...
LANDMARK CHEMOTHERAPY TRIALS in Carcinoma Ovary.pptx
The Utilization of Bevacizumab in Patients with Advanced Ovarian Cancer ...
Bevacizumab and platinum-based combinations for recurrent ovarian ...
Cervix landmark trials- kiran | PPTX
Frontiers | New hopes and promises in the treatment of ovarian cancer ...
(PDF) Among patients with advanced ovarian carcinoma, who benefits from ...
Comparison of the Kaplan–Meier curves for PFS between GOG218 and the ...
Figure 2 from Bevacizumab and paclitaxel-carboplatin chemotherapy and ...
PPT - Session IV Professor Stanley Kaye Royal Marsden Hospital London ...
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary ...
PPT - Ovarian Cancer: Standards of Care and New Opportunities ...
Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group ...
30142-X/asset/7433a859-2d52-4d63-825a-8e3631ac708a/main.assets/gr3_lrg.jpg)
